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background: Transvenous permanent pacing leads may result in native tricuspid valve dysfunction, particularly regurgitation. Limited data is 
available regarding potential adverse effects of transvenous leads implanted across bioprosthetic tricuspid valves (BTV). The aim of this study is to 
assess BTV function in patients with a transvenous right ventricular lead in comparison to those with epicardial pacing.
methods: A retrospective review of patients with BTV who underwent placement of a right ventricular transvenous or epicardial pacing lead 
was conducted at our institution. Patient data including surgical, pacemaker and echocardiographic records were collected. BTV stenosis and/or 
moderate or greater degree of regurgitation was considered as prosthesis malfunction.
results: Thirty four patients (29 females) underwent insertion of a permanent pacemaker following BTV implantation. Underlying valve pathology 
was rheumatic (n=27), Ebstein malformation (n=5) or other (n=2). Fourteen patients had prior TV surgery and 19 had concomitant valvular surgery. 
Patients were followed by serial echocardiographic studies for a mean duration of 49.2 months (1.1-147.3). Two of 18 patients with a transvenous 
lead had BTV malfunction identified at 19.5 and 32.4 months post-implantation. Two of 16 patients with epicardial leads had BTV malfunction 
identified at 11.1 and 85.6 months, respectively.
conclusions: The risk of developing BTV malfunction was not increased at intermediate term follow-up in patients who undergo insertion of a 
permanent transvenous right ventricular pacing lead as compared to those with epicardial leads.
